New therapy aims to ease fear of cancer return for lung patients and partners
NCT ID NCT07588347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new program called ADAPT, which is a type of talk therapy for lung cancer patients and their spouses. The goal is to help both partners feel less afraid of the cancer coming back. About 72 couples will try the program during chemotherapy or radiation and answer questionnaires to see if it helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 72 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria Patients: * Diagnosis of primary lung cancer confirmed by pathological examination. * Age ≥ 22 years for men and ≥ 20 years for women (legal marriage age in China). * Have undergone lung cancer surgery and are scheduled to receive the first round of radiotherapy and/or chemotherapy treatment * Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) score ≥ 13, indicating moderate-to-severe FCR. * Eastern Cooperative Oncology Group (ECOG) ≤2. * Aware of their diagnosis and willing to participate voluntarily. * Normal cognitive function (Montreal Cognitive Assessment \[MoCA\] score ≥ 26), alert and conscious, and able and willing to communicate their thoughts. Spouse Caregivers: * Identified by the patient as the primary caregiver, providing ≥ 50% of care in the past 2 weeks. * Legally married to the patient. * Age ≥ 22 years for men and ≥ 20 years for women. * Normal cognitive function (MoCA score ≥ 26), no diagnosed mental disorders, able to communicate effectively, and willing to share their thoughts. Exclusion Criteria Patients: * Diagnosed mental disorders or currently receiving psychiatric treatment. * Presence of personality disorders, intellectual disability, memory disorders, brain injury, or neurological disease. * Concurrent malignant tumors in other organs. * Severe complications (e.g., chest pain and/or dyspnea due to pleural tumor invasion). * Spouse caregiver unwilling to participate. * History of upper limb fractures or surgery resulting in impaired hand function. * Participation in other similar psychological interventions. Spouse Caregivers: * Presence of serious comorbid conditions (e.g., respiratory failure, malignant tumors, or other critical illnesses). * Patient unwilling to participate. * Participation in other research studies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acceptance and commitment therapy are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Magnetic pulses to the brain may help lung cancer patients sleep after surgery
- A new twist on lung rehab: helping the helpers
- Exercise as a cancer ally: could a bike ride supercharge immunotherapy?
- A new MRI approach could spare patients unnecessary lung biopsies
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Light-Based blood test may spot lung cancer early